Thrivent Financial for Lutherans’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,892	Closed	-$203K	–	2465
2022 Q1	$203K	Buy	+5,892	New	+$208K	﹤0.01%	2446
2021 Q4	–	Hold	0	–	–	–	720
2021 Q3	–	Hold	0	–	–	–	775
2021 Q2	–	Hold	0	–	–	–	728
2021 Q1	–	Hold	0	–	–	–	708
2020 Q4	–	Hold	0	–	–	–	468
2020 Q3	–	Hold	0	–	–	–	488
2020 Q2	–	Hold	0	–	–	–	663
2020 Q1	–	Hold	0	–	–	–	603

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $46.7B AUM 50.59% 1-Year Est. Return

Thrivent Financial for Lutherans's IDNA Position: Q2 2022 in Review

Thrivent Financial for Lutherans sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2022, closing a stake of 5,892 shares — an estimated $203K sold.

Thrivent Financial for Lutherans first reported a position in IDNA in Q1 2022 and held it in 1 quarter. The position peaked at $203K in Q1 2022. 73 funds tracked by Wall St. Rank hold IDNA as of Q2 2022.

Thrivent Financial for Lutherans reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2022 after selling out during the quarter.
Thrivent Financial for Lutherans sold 5,892 iShares Genomics Immunology and Healthcare ETF shares in Q2 2022, an estimated $203K.
Thrivent Financial for Lutherans first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2022 and held it in 1 quarter.
Thrivent Financial for Lutherans's iShares Genomics Immunology and Healthcare ETF position peaked at $203K in Q1 2022.
73 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2022.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2022, filed 16 Aug 2022.